Abstract

BackgroundKounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.Case presentationA 62-year-old man with recurrent bladder cancer underwent an intra-iliac artery epirubicin injection. After the injection, he developed chest pain and a systemic allergic reaction, with electrocardiographic alterations and elevated troponin-I levels. Emergent coronary angiography showed right coronary artery spasm and no stenosis of the other coronary arteries. This reaction was considered compatible with an allergic coronary vasospasm. A diagnosis of Kounis syndrome was made.ConclusionsKounis syndrome is common, but a prompt diagnosis is often not possible. This case is the first to suggest that an intraarterial epirubicin injection could potentially be one of its triggers. All physicians should be aware of the pathophysiology of this condition to better recognize it and start appropriate treatment; this will prevent aggravation of the vasospastic cardiac attacks and yield a better outcome.

Highlights

  • Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity

  • Kounis syndrome is common, but a prompt diagnosis is often not possible. This case is the first to sug‐ gest that an intraarterial epirubicin injection could potentially be one of its triggers

  • The patient was monitored in the cardiac intensive care unit (CCU)

Read more

Summary

Conclusions

But a prompt diagnosis is often not possible. This case is the first to sug‐ gest that an intraarterial epirubicin injection could potentially be one of its triggers.

Background
Discussion and conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.